Print 18 July 2017
At its meeting on July 13, the Russian government approved the draft federal laws “On Amendments to the Federal Law “On Circulation of Medicines” and “On Amendments to the Code of the Russian Federation on Administrative Offenses.”
In particular, the draft laws provide for implementing, across Russia, a federal information system to monitor the circulation of medicines for human use from the manufacturer to the end consumer by using control (identification) marks for identifying the medicines. It is suggested to introduce the administrative liability for manufacturing or selling the medicines for human use without control marks, in violation of the established procedure for their application, untimely entry or entry of false information into the system for monitoring the circulation of medicines.
The government decided to submit these documents to the State Duma in accordance with the established procedure.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.